(see Supplementary Appendix 6, on the Arthritis & Rheumatology web site at http://onlin elibr ary.wiley.com/doi/10.1002/art.41042/ abstract Three trials of methotrexate with negative results tested doses of â‰¤10 mg weekly, and the lack of benefit may reflect the low doses used A phase II study of tofacitinib showed benefit in both clinical and imaging outcomes of axial disease over 12 weeks http://onlin e libr ary.wiley.com/doi/10.1002/art.41042/ abstract In adults with active AS despite